Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
abetting, acid, ACTIMMUNE, afucosylated, ago, alleviate, analyst, anticipatory, antineutrophil, artificial, artificially, Aug, automated, aware, bar, Becerra, BEKEMV, Belgium, BESPONSA, Bradner, Brazil, bulging, BUPHENYL, busch, cafraglutide, CAS, cascade, CDT, Cencora, characteristic, chemical, chemorefractory, Cheri, choice, CIO, CISO, clause, Clearwater, clinician, CMO, colon, Columbia, contraindicated, conventional, conversion, CRC, CRCC, CTO, curb, cyber, Daxdilimab, Dazodalibep, debilitating, Dec, Deerfield, dendritic, Denmark, diffuse, digital, diplopia, discoid, disorder, diverging, doser, DTI, duty, earliest, eleven, encountered, entirety, ERBITUX, Erroneously, evade, Farmaceutico, fiduciary, fight, Fipaxalparant, FL, flare, forensic, frontline, furthest, gas, gave, Gaza, gender, German, gout, greatest, greenhouse, hardware, harmonize, Harvard, hyperthyroidism, idiopathic, IL, impasse, inaugural, inopportune, Inspire, IP, irreversible, isatuximab, ISDA, Israel, iterative, judgement, justify, kappa, KRYSTEXXA, Laboratorio, layered, legacy, Lek, Leon, LEQVIO, Ltda, lysophosphatidic, maridebart, Martin, matthew, mCRC, mechanism, mentorship, Merck, metric, misalignment, misconfiguration, misleading, mismanagement, mOS, multidimensional, Munich, myasthenia, Nevada, nontraditional, Nullity, OPDIVO, operationally, optica, Organisation, organizational, orphan, oxidase, Parliament, PBM, pegloticase, PENNSAID, pension, PMR, PREA, predecessor, pretrial, proceed, PROCYSBI, proficiency, prove, PSU, purportedly, Pushtronex, Quimico, QUINSAIR, race, racial, RAS, RAVICTI, reargument, rectum, regime, regorafenib, RI, sat, satisfactory, SCLC, SOTYKTU, specialist, spectrum, stack, stopgap, struck, Tampa, team, TED, TEPEZZA, tighter, tipiracil, Topical, toughest, trifluridine, tyler, unaffordable, unified, unjust, unrelated, unremitted, UPLIZNA, upskilling, uric, UTB, viability, vision, weak, Wezlana, xanthine
Removed:
accomplishment, accreted, affirmative, affirming, Alendronate, alirocumab, Alkem, allegation, amending, Amneal, ANDA, Anderson, Annora, antiresorptive, Apotex, Aurobindo, Aventisub, avoid, BAFF, belief, Biden, BioVex, black, border, breakaway, brodalumab, Businesswomen, cancellation, certiorari, chance, closed, coalition, college, column, concurrently, conjugate, consultation, count, counting, dedesignate, dental, deplete, disagree, discontinue, discounting, discovering, disputing, disruptive, distancing, doctor, door, DRL, ease, ebb, Emcure, employing, enablement, enduring, ESA, exacerbated, exchanged, experiencing, failing, fever, filgrastim, fluidity, formula, founding, Fulphila, fungible, genital, Glenmark, governed, grantee, Heritage, Hetero, holding, hospital, ICOSL, immunogenicity, immunosuppressive, importing, improved, infection, Institutional, instructing, insulin, issuable, judgmental, jury, leaving, linda, lookback, Los, louie, magnitude, Mankind, MBA, Methotrexate, mind, minimize, modification, monetization, MSN, navigate, neuroscience, noncancelable, notify, Nucleic, occupancy, OneTen, onset, optional, ordered, outbreak, overturning, pegylated, penalize, pendency, Pharmascience, phased, prediction, Prinston, producing, proteasome, raloxifene, reallocation, reassessment, receivable, recruiting, rehearing, reimpose, reinstate, reinstatement, remand, replace, resurgence, returned, Rozibafusp, selecting, Shilpa, skill, spent, stayed, stemming, stipulated, substituting, successor, surge, temperature, tendered, tentative, terminating, timeline, Torrent, trajectory, transition, trip, UDENYCA, unanimously, unapproved, unavailability, underrepresentation, Unichem, unlocking, unravel, ustekinumab, vaccination, validly, verdict, wider, worked, worsen, writ
Filing tables
Filing exhibits
- 10-K Annual report
- 4.33 Description of Securities
- 10.2 Form of Grant of Stock Option Agreement
- 10.3 Form of Restricted Stock Unit Agreement
- 10.5 Form of Performance Unit Agreement
- 10.6 Amgen Inc. 2009 Director Equity Incentive Program
- 10.9 Fifth Amendment to Supplemental Retirement Plan
- 10.12 Fourth Amendment to Nonqualified Deferred Compensation Plan
- 10.14 Agreement Between Amgen Inc. and James Bradner
- 10.17 Collaboration and License Agreement Between Amgen Inc. and Celltech R&D Limited
- 10.17 Amendment No 2 to Celltech Collaboration and License Agreement
- 10.22 Letter Agreement Re Fte Rates
- 21 Subsidiaries of the Company
- 31 Rule 13A-14(A) Certifications
- 32 Section 1350 Certifications
- 97 Policy on Recovery of Erroneously Awarded Compensation
- Download Excel data file
- View Excel data file
Related press release
Associated AMGN transcripts
AMGN similar filings
Filing view
External links
Exhibit 10.12.4
FOURTH AMENDMENT TO THE
AMGEN NONQUALIFIED DEFERRED COMPENSATION PLAN
AS AMENDED AND RESTATED EFFECTIVE OCTOBER 16, 2013
The Amgen Nonqualified Deferred Compensation Plan, as Amended and Restated Effective October 16, 2013, and as subsequently amended (the “Plan”), is hereby amended, effective January 1, 2024, as follows:
1.Appendix A is amended by adding the following entity to the end of the list of subsidiaries and affiliates designated as Employers:
“Horizon Therapeutics USA, Inc. and its U.S. subsidiaries”
To record this Fourth Amendment to the Plan as set forth herein, the Company has caused its authorized officer to execute this document this _18__ day of December, 2023.
AMGEN INC.
By: /s/ Derek Miller
Name: Derek Miller
Title: Senior Vice President, Human Resources